Form 144: IRWD RSUs to be sold through E Trade on 08/11/2025

Rhea-AI Filing Summary

This Form 144 notifies a proposed sale of 8,281 shares of Ironwood Pharmaceuticals, Inc. Class A common stock with an aggregate market value of $7,287.28. The sale is listed to occur through E Trade Securities LLC on the Nasdaq exchange on 08/11/2025. The securities were originally acquired as a Restricted Stock Unit award under the issuer's 2019 Equity Incentive Plan on 08/02/2021, with 19,973 units shown as acquired on that date.

The filing reports 161,819,848 shares outstanding, and indicates no securities sold in the past three months by the person for whose account the sale is filed. The notice includes the filer's representation that they do not know of any undisclosed material adverse information regarding the issuer.

Insights

Securities Analyst

TL;DR: Routine Rule 144 disclosure; proposed sale is immaterial versus outstanding shares and is unlikely to move markets.

The filing details a small planned disposition of 8,281 shares (aggregate $7,287.28) through E Trade on Nasdaq. Given the issuer's reported 161,819,848 shares outstanding, the volume is a de minimis portion of the float. The securities were issued as RSUs on 08/02/2021, and the filer reports no sales in the prior three months, which reduces the likelihood this represents ongoing substantial insider liquidation. Overall, this is a routine, compliance-focused disclosure with neutral investor impact.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 procedures; includes standard representation about absence of undisclosed material information.

The notice documents a sale of RSU-derived shares and names the executing broker, supporting transparency around insider or affiliated-party transactions. The filer’s signed representation that no material adverse information is undisclosed is the customary attestation on this form. No prior three-month sales are reported, and the filing does not identify any governance or compliance issues. From a governance perspective this is a standard, non-material reportable transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	E Trade Securities LLC 3 Edison Drive Alpharetta GA 30005	8281	7287.28	161819848	08/11/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	08/02/2021	Restricted Stock Unit award granted pursuant to Issuer's 2019 Equity Incentive Plan, subject to vesting requirements	Ironwood Pharmaceuticals, Inc.			19973	08/02/2021	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the IRWD Form 144 report?

The filing reports a proposed sale of 8,281 Class A shares of Ironwood (IRWD) with aggregate market value $7,287.28.

When and where is the sale to occur for IRWD shares?

The sale is listed to be executed via E Trade Securities LLC on the Nasdaq exchange on 08/11/2025.

How were the shares being sold acquired?

The shares were acquired on 08/02/2021 as a Restricted Stock Unit award under Ironwood's 2019 Equity Incentive Plan; 19,973 units are listed as acquired on that date.

How many shares does Ironwood have outstanding and is the sale a large portion?

The filing shows 161,819,848 shares outstanding; the planned sale of 8,281 shares is a very small fraction of outstanding shares.

Has the filer sold any Ironwood securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the sale is filed.